These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27548469)

  • 21. β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study.
    Nielsen PB; Larsen TB; Gorst-Rasmussen A; Skjøth F; Lip GY
    Circ Heart Fail; 2016 Feb; 9(2):e002597. PubMed ID: 26823497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive value of the heart rate reserve in patients with permanent atrial fibrillation treated according to a strict rate-control strategy.
    De Schryver N; Scavée C; Marchandise S; Pasquet A; de Meester C; le Polain de Waroux JB
    Europace; 2014 Aug; 16(8):1125-30. PubMed ID: 24599938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fragmented QRS predicts heart failure progression in patients with hypertrophic cardiomyopathy.
    Nomura A; Konno T; Fujita T; Tanaka Y; Nagata Y; Tsuda T; Hodatsu A; Sakata K; Nakamura H; Kawashiri MA; Fujino N; Yamagishi M; Hayashi K
    Circ J; 2015; 79(1):136-43. PubMed ID: 25381793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral arterial disease and atrial fibrillation and risk of stroke, heart failure hospitalization and cardiovascular death: A nationwide cohort study.
    Lin YS; Tung TH; Wang J; Chen YF; Chen TH; Lin MS; Chi CC; Chen MC
    Int J Cardiol; 2016 Jan; 203():204-11. PubMed ID: 26512838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reassessing Risk Factors in Pediatric Patients With Pacemakers Implanted for Atrioventricular Block: The Impact of Nonsustained Ventricular Tachycardia.
    Niu MC; Morris SA; Krenek M; DE LA Uz CM; Pedroza C; Miyake CY; Kim JJ; Valdés SO
    J Cardiovasc Electrophysiol; 2016 Apr; 27(4):471-9. PubMed ID: 27074776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrocardiographic Preexcitation and Risk of Cardiovascular Morbidity and Mortality: Results From the Copenhagen ECG Study.
    Skov MW; Rasmussen PV; Ghouse J; Hansen SM; Graff C; Olesen MS; Pietersen A; Torp-Pedersen C; Haunsø S; Køber L; Svendsen JH; Holst AG; Nielsen JB
    Circ Arrhythm Electrophysiol; 2017 Jun; 10(6):. PubMed ID: 28576781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-Sustained Ventricular Tachycardia Episodes Predict Future Hospitalization in ICD Recipients with Heart Failure.
    Uçar FM; Yilmaztepe MA; Taylan G; Aktoz M
    Arq Bras Cardiol; 2017 Oct; 109(4):284-289. PubMed ID: 28977051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Newly detected atrial high rate episodes predict long-term mortality outcomes in patients with permanent pacemakers.
    Gonzalez M; Keating RJ; Markowitz SM; Liu CF; Thomas G; Ip JE; Lerman BB; Cheung JW
    Heart Rhythm; 2014 Dec; 11(12):2214-21. PubMed ID: 25131667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic role of CMR in patients presenting with ventricular arrhythmias.
    Dawson DK; Hawlisch K; Prescott G; Roussin I; Di Pietro E; Deac M; Wong J; Frenneaux MP; Pennell DJ; Prasad SK
    JACC Cardiovasc Imaging; 2013 Mar; 6(3):335-44. PubMed ID: 23433931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 30-year nationwide trends in incidence of atrial fibrillation in Denmark and associated 5-year risk of heart failure, stroke, and death.
    Schmidt M; Ulrichsen SP; Pedersen L; Bøtker HE; Nielsen JC; Sørensen HT
    Int J Cardiol; 2016 Dec; 225():30-36. PubMed ID: 27705839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients.
    Genovesi S; Vincenti A; Rossi E; Pogliani D; Acquistapace I; Stella A; Valsecchi MG
    Am J Kidney Dis; 2008 Feb; 51(2):255-62. PubMed ID: 18215703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of nonsustained ventricular tachycardia on reverse remodeling, heart failure, and treated ventricular tachyarrhythmias in MADIT-CRT.
    Mittal S; Aktas MK; Moss AJ; McNitt S; Kutyifa V; Steinberg JS; Zareba W
    J Cardiovasc Electrophysiol; 2014 Oct; 25(10):1082-7. PubMed ID: 24862906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An observational study on the effect of premature ventricular complex burden on long-term outcome.
    Lin CY; Chang SL; Lin YJ; Chen YY; Lo LW; Hu YF; Tuan TC; Chao TF; Chung FP; Liao JN; Chang YT; Lin CH; Walia R; Te ALD; Yamada S; Chiou CW; Tsao HM; Chen SA
    Medicine (Baltimore); 2017 Jan; 96(1):e5476. PubMed ID: 28072689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Causes of Death and Influencing Factors in Patients with Atrial Fibrillation.
    Fauchier L; Villejoubert O; Clementy N; Bernard A; Pierre B; Angoulvant D; Ivanes F; Babuty D; Lip GY
    Am J Med; 2016 Dec; 129(12):1278-1287. PubMed ID: 27476087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Significance of Nonsustained Ventricular Tachycardia Episodes Occurring Early After Implantable Cardioverter-Defibrillator Implantation Among Patients With Left Ventricular Dysfunction.
    Jiménez-Candil J; Hernández J; Perdiguero P; Martín A; Moríñigo J; Bravo L; Durán O; Sánchez PL
    Am J Cardiol; 2016 Nov; 118(10):1503-1510. PubMed ID: 27634031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of recurrent ventricular arrhythmia or death in 300 consecutive patients with ischemic heart disease who experienced aborted sudden death: data from the Leiden out-of-hospital cardiac arrest study.
    Kiès P; Boersma E; Bax JJ; van der Burg AE; Bootsma M; van Erven L; van der Wall EE; Schalij MJ
    J Cardiovasc Electrophysiol; 2005 Oct; 16(10):1049-56. PubMed ID: 16191114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doppler-derived left ventricular negative dP/dt as a predictor of atrial fibrillation or ischemic stroke in patients with degenerative mitral regurgitation and normal ejection fraction.
    Yi JE; Lee DH; Cho EJ; Jeon HK; Jung HO; Youn HJ
    Echocardiography; 2014 Mar; 31(3):285-92. PubMed ID: 24007645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors predisposing to ventricular proarrhythmia during antiarrhythmic drug therapy for atrial fibrillation in patients with structurally normal heart.
    Lin CY; Lin YJ; Lo LW; Chen YY; Chong E; Chang SL; Chung FP; Chao TF; Hu YF; Tuan TC; Liao JN; Chang Y; Chien KL; Chiou CW; Chen SA
    Heart Rhythm; 2015 Jul; 12(7):1490-500. PubMed ID: 25889809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial.
    Lee AY; Kutyifa V; Ruwald MH; McNitt S; Polonsky B; Zareba W; Moss AJ; Ruwald AC
    Heart Rhythm; 2015 Sep; 12(9):2010-7. PubMed ID: 26025322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
    O'Meara E; Khairy P; Blanchet MC; de Denus S; Pedersen OD; Levesque S; Talajic M; Ducharme A; White M; Racine N; Rouleau JL; Tardif JC; Roy D;
    Circ Heart Fail; 2012 Sep; 5(5):586-93. PubMed ID: 22798522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.